Dental filling and alveoli repair studies have been widely reported. The alveoli bone repair and loss after dental extraction stimulate the search for substances that impair these processes. Despite the fact that the first studies using microCT in rodent maxillae are from 2010, this analysis represents the most efficient method to investigate the bone repair process [16]. Additionally, the correlation of microCT data with histological evaluations can provide precise information regarding bone remodeling. Herein, this study investigated the effect of BA in alveolus repair after dental extraction, with or without the association with bone graft, and demonstrated that the application of this boron-derived compound did not affect bone remodeling, regardless of its association with the bone graft application.
The use of BA demonstrates an osteogenic potential by stimulating human bone marrow-derived stromal cells gene markers related to cell proliferation [11]. Additionally, in MC3T3-E1 cells, which is a mouse osteoblast cell line, BA acted on cell proliferation and induced the mRNA expression of mineralized tissue-associated proteins [12] Furthermore, it was recently observed that BA regulated the tuftelin1 gene in osteoblasts, demonstrating its role in the alveolus bone and dental formation [8]. Due to this, it could be suggested that the association between BA and a biomaterial could be an alternative management to preserve the alveolus ridge; nevertheless, our data failed to confirm this hypothesis.
The dietary BA supplementation [9, 10, 17, 18] and local BA application [5–7] to promote the osteogenic process have been widely investigated. However, the local BA filling of the dental alveolus is an alternative therapeutic route that has not been investigated. Uysal et al [18] claim that local BA application minimizes the dietary BA supplementation-evoked adverse effects and delimitates the exposed area to the substance.
Gölge et al [5] observed that the local BA application in fractured femur rats displayed enhanced bone repair. Also, in rabbits, the association between BA and an autogenous bone/xenograft mixture in maxillary sinus augmentation demonstrated an improved bone repair in a 4-week period of observation, with higher expression of alkaline phosphatase (ALP), osteocalcin, proliferating cell nuclear antigen (PCNA), and vascular endothelial growth factor (VEGF), suggesting that the osteoblasts differentiation and bone synthesis are promoted by the presence of BA [6]. Thus, the improved bone repair might be related to the higher activity of osteoclast and osteoblasts throughout the four weeks of the experiment [6, 17]. In this study, the initial bone repair process was investigated using microCT and histological analysis in a 4-week period (28 days), but with no demonstration of BA impact in bone remodeling.
Hassumi et al.[19] characterized the alveolar repair at 7, 14, and 28 days by immunohistochemical, molecular and microCT analyses. The authors described highest values BV, BV/TV, Tb.Th, Tb.N and lowest values in Po-tot and Tb.Sp at 28 days post-extraction. In our study, the data compared to the control group with the tooth extraction + BA group reflect the inverse situation, suggesting that there is a delay in repair from bone microarchitecture analysis in the presence of the BA.
The use of bone substitutes in alveoli filling aims to prevent the ridge dimensions. Lyophilized bone grafts, porous hydroxyapatite, and calcium phosphate-based are among the most used biomaterials [1]. Here, a lyophilized bovine bone graft was used for its slow degradation and to guarantee alveoli volume, which is important in procedures that aim to conserve the alveolus ridge [3].
The presence of bone graft, BA, and their association failed to demonstrated differences during the bone remodeling process, and failed to induce an enhanced repair in the alveolus bone. The absence of immunostaining investigation regarding osteoclastic and osteoblastic activity limits the analyses of the whole bone repair scenario, seen that these markers could help gain further insight of the actions of BA in the alveolus bone. Concerning the histological evaluation, the descriptive analysis did not show notable differences between the experimental groups exposed to BA and between groups not. Nonetheless, histological samples from the BA rats demonstrated regions with inflammatory cells and connective tissue, denoting a delay in the repair process. These findings go against previous studies which evaluated bone repair in dental alveoli from rats, where the presence of residual inflammatory cells was undetected in this healing time [4, 19–21]. In this study, the rats that received the local application of bone graft in the dental alveolus demonstrated a delayed bone repair in the microCT and histological analyses, which was expected. The presence of connective tissue with the biomaterial and the delayed healing process is well seen in literature data [3, 22–24]. Nonetheless, in this study, the BA experimental group demonstrated less organized osteoblasts surrounding the bone graft particles, different from what occurred in the bone graft group without the association with BA. It is possible to suspect that the BA filling might evoke toxicity and postpone the repair process due to the chosen BA dosage since previous research describe that the BA can inhibit osteoblast synthesis when used in higher concentrations [12, 25]. Notably, the non-toxic dosage of BA varied from 3 mg/kg to 8.7 mg/kg in previous studies, demonstrating interesting results regarding bone repair[5–7] According to previous studies, dietary BA 18–20 mg/kg and 6 µg/ml in mesenchymal cell culture display toxicity, nonetheless, toxic dosages for local applications lacks information [25, 26]. In this study, it was applied 8 mg/kg of BA locally, into the alveolus after dental extraction, associated or not to bone graft in equal parts, based on a previous report [5]. Nonetheless, other concentrations might gain further insights since this study failed to demonstrate significant results regarding BA and its possible osteogenic properties. The association of BA with a bone graft was firstly described by Kömürcü et al [7], in a study regarding autogenous bone associated with BA in posterolateral spinal fusion. The authors observed an improved repair process histologically when compared to the autogenous bone isolated [7]. Afterward, Ulu et al[6] identified an increased initial bone repair with BA, suggesting its use to enhance the bone formation process and to reduce the bone graft absorption [6]. In this investigation, the bone remodeling did not differ when the bone graft was associated with BA, and, similar to Kömürcü et al [7], it was not possible to observe an increase in bone repair process when pure BA was applied locally.